Fig. 2From: Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort studyVisual analogue scale (VAS) well-being scores at baseline and follow. Boxplots represent median and interquartile range. Connected dots represent measurements from the same patient. JAMAR: juvenile arthritis multidimensional assessment reportBack to article page